Who
John Leite
Global Chief Commercial Off
Company insider
Files Form 4 as: Global Chief Commercial Off, Veracyte.
In numbers
- Trades disclosed
- 43
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $3.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Sep 2023
- Last trade
- 21 Sep 2026
- Last filed
- 22 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Sep 2026filed 22 Sep 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $161K4,015 at $40.00 | filing |
| 21 Sep 2026filed 22 Sep 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $161K4,015 at $40.00 | filing |
| 2 Sep 2026filed 4 Sep 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $178K3,961 at $44.88 | filing |
| 2 Sep 2026filed 4 Sep 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $178K3,961 at $44.88 | filing |
| 4 Jun 2026filed 4 Jun 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $700K13,975 at $50.07 | filing |
| 4 Jun 2026filed 4 Jun 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $700K13,975 at $50.07 | filing |
| 2 Jun 2026filed 4 Jun 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $194K4,059 at $47.80 | filing |
| 2 Jun 2026filed 4 Jun 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $194K4,059 at $47.80 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code A | —36,181 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code A | —6,578 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code A | —36,181 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code A | —6,578 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $185K5,260 at $35.19 | filing |
| 4 Mar 2026filed 6 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $185K5,260 at $35.19 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $271K7,517 at $36.01 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $271K7,517 at $36.01 | filing |
| 26 Feb 2026filed 2 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code A | —47,149 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $345K8,905 at $38.75 | filing |
| 26 Feb 2026filed 2 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code A | —47,149 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $345K8,905 at $38.75 | filing |
News
John Leite Sells 4,015 Shares of Veracyte (NASDAQ:VCYT) Stocktickerreport.com · 22 Sep 2026
1 headline in the last 90 days name John Leite; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.